• Gröbner et al. (2018). The landscape of genomic alterations across childhood cancers. Nature.
  • Gryder et al. (2017). PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. Cancer Discovery.
  • Gardiner et al. (2017). C/EBP\upbeta{}{-}{1} promotes transformation and chemoresistance in Ewing sarcoma cells. Oncotarget.
  • Stewart et al. (2016). The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities. Dev. Biol.
  • Zhang et al. (2015). Germline Mutations in Predisposition Genes in Pediatric Cancer. N. Engl. J. Med.
  • Topka et al. (2015). Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia. {PLOS} Genetics.
  • Xu et al. (2015). Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat. Commun.
  • Kuhlen, and Borkhardt (2015). Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing. Eur. J. Pediatr.
  • Chen et al. (2015). Pediatric solid tumor genomics and developmental pliancy. Oncogene.
  • Spector et al. (2015). Genetic and Nongenetic Risk Factors for Childhood Cancer. Pediatr. Clin. North Am.
  • Maris, and Knudson (2015). Revisiting tissue specificity of germline cancer predisposing mutations. Nat. Rev. Cancer.
  • Xu et al. (2014). Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature.
  • Leithner et al. (2014). PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene.
  • Huether et al. (2014). The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat. Commun.
  • Rahman (2014). Realizing the promise of cancer predisposition genes. Nature.
  • Vogelstein et al. (2013). Cancer Genome Landscapes. Science.
  • Shah et al. (2011). HLA homozygosity and haplotype bias among patients with chronic lymphocytic leukemia: implications for disease control by physiological immune surveillance. Leukemia.